Header Logo

Patricia Boyle

Concepts (548)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Aging
111
2023
1544
11.370
Why?
Cognition
72
2023
1339
9.080
Why?
Health Literacy
19
2023
108
8.660
Why?
Alzheimer Disease
80
2023
2109
8.290
Why?
Cognitive Dysfunction
52
2025
1061
7.600
Why?
Decision Making
21
2023
223
7.360
Why?
Cognition Disorders
59
2019
985
6.350
Why?
Aged, 80 and over
189
2025
4777
6.280
Why?
Aged
221
2025
8997
5.720
Why?
Brain
63
2023
1649
5.640
Why?
Independent Living
19
2025
322
5.030
Why?
Longitudinal Studies
78
2025
1368
4.350
Why?
Neuropsychological Tests
81
2022
1196
4.200
Why?
Dementia
30
2021
560
4.180
Why?
Female
218
2025
15212
4.140
Why?
Male
221
2025
14772
4.110
Why?
Humans
273
2025
27072
3.890
Why?
Cohort Studies
82
2023
1890
3.170
Why?
Cerebral Amyloid Angiopathy
7
2023
111
2.340
Why?
Delivery of Health Care
7
2023
144
2.310
Why?
Neurodegenerative Diseases
7
2021
125
2.170
Why?
Cognitive Aging
5
2021
78
2.080
Why?
Delay Discounting
4
2023
24
1.950
Why?
TDP-43 Proteinopathies
8
2021
112
1.940
Why?
Financial Management
5
2020
23
1.890
Why?
DNA-Binding Proteins
10
2019
276
1.880
Why?
Activities of Daily Living
27
2014
595
1.870
Why?
Memory, Episodic
10
2022
116
1.840
Why?
White Matter
6
2020
134
1.780
Why?
Educational Status
20
2023
293
1.770
Why?
Hippocampus
10
2022
273
1.660
Why?
Neuropathology
5
2022
81
1.520
Why?
Memory
23
2018
297
1.500
Why?
Choice Behavior
4
2019
46
1.500
Why?
Residence Characteristics
16
2021
214
1.440
Why?
Magnetic Resonance Imaging
18
2023
1112
1.420
Why?
Middle Aged
81
2021
8923
1.390
Why?
Economics
4
2019
18
1.380
Why?
Dementia, Vascular
9
2018
46
1.380
Why?
Disease Progression
21
2021
673
1.360
Why?
Blood Glucose
2
2022
104
1.340
Why?
Income
8
2023
80
1.330
Why?
Age Factors
40
2021
766
1.280
Why?
Mortality
10
2021
89
1.260
Why?
Autopsy
18
2021
344
1.240
Why?
Hospitalization
4
2019
300
1.230
Why?
Motor Activity
16
2015
323
1.200
Why?
Risk Factors
41
2022
2302
1.190
Why?
Literacy
2
2019
17
1.190
Why?
Lewy Bodies
12
2021
192
1.180
Why?
Amyloid beta-Peptides
8
2023
324
1.170
Why?
Financing, Personal
5
2020
22
1.120
Why?
Fraud
4
2022
21
1.120
Why?
Neoplasms
9
2009
237
1.100
Why?
Prospective Studies
22
2025
1778
1.090
Why?
Muscle Strength
11
2012
130
1.040
Why?
Perception
3
2019
77
1.030
Why?
Goals
3
2010
43
0.990
Why?
Quality of Life
10
2015
629
0.970
Why?
Geriatric Assessment
12
2015
207
0.970
Why?
Disability Evaluation
9
2015
264
0.960
Why?
Loneliness
4
2020
59
0.940
Why?
Nerve Degeneration
3
2014
48
0.930
Why?
Nervous System Diseases
5
2019
117
0.910
Why?
Incidence
32
2019
759
0.910
Why?
Neurofibrillary Tangles
10
2019
193
0.910
Why?
Chicago
15
2025
949
0.900
Why?
Crime Victims
2
2022
32
0.890
Why?
Proportional Hazards Models
17
2019
347
0.890
Why?
Sex Factors
29
2019
464
0.880
Why?
Medicare
3
2023
118
0.880
Why?
Hypertension
3
2022
192
0.860
Why?
Government
1
2023
3
0.860
Why?
Apolipoprotein E4
8
2025
263
0.860
Why?
Awareness
5
2019
42
0.850
Why?
Life Style
4
2021
186
0.810
Why?
Cross-Sectional Studies
8
2023
891
0.800
Why?
Memory, Short-Term
4
2019
97
0.800
Why?
Blood Pressure
4
2022
195
0.800
Why?
Arteriolosclerosis
2
2023
78
0.790
Why?
Information Literacy
3
2019
9
0.780
Why?
Brain Mapping
4
2018
147
0.780
Why?
Atherosclerosis
1
2023
53
0.780
Why?
Chronic Disease
4
2017
415
0.770
Why?
Metacognition
1
2021
5
0.760
Why?
Elder Abuse
1
2022
35
0.750
Why?
Cerebral Arterial Diseases
1
2021
9
0.740
Why?
Age of Onset
2
2021
94
0.740
Why?
Reward
2
2019
23
0.730
Why?
Follow-Up Studies
23
2019
1792
0.700
Why?
Patient Acceptance of Health Care
2
2019
77
0.700
Why?
Limbic Encephalitis
1
2020
13
0.690
Why?
Plaque, Amyloid
7
2019
145
0.690
Why?
Memory Disorders
9
2019
159
0.670
Why?
Learning
2
2018
71
0.670
Why?
Adult
51
2022
7831
0.670
Why?
Depression
9
2021
444
0.650
Why?
Neurocognitive Disorders
1
2019
12
0.650
Why?
Stroke
1
2023
261
0.640
Why?
Prostatic Hyperplasia
4
2004
9
0.640
Why?
Prodromal Symptoms
1
2019
17
0.620
Why?
Risk
10
2019
204
0.620
Why?
Cerebral Infarction
8
2015
147
0.600
Why?
Agnosia
2
2016
9
0.600
Why?
Mobility Limitation
7
2019
94
0.590
Why?
Intracranial Arteriosclerosis
1
2018
54
0.570
Why?
United States
16
2023
2035
0.560
Why?
Disabled Persons
6
2019
122
0.550
Why?
Health Knowledge, Attitudes, Practice
1
2018
164
0.540
Why?
Ambulatory Care
1
2017
69
0.540
Why?
Diabetes Mellitus, Type 2
1
2018
167
0.520
Why?
Postmortem Changes
1
2016
31
0.520
Why?
Temporal Lobe
5
2020
83
0.510
Why?
Frail Elderly
3
2014
51
0.500
Why?
Intention
3
2010
21
0.500
Why?
Cognitive Reserve
3
2021
39
0.480
Why?
Regression Analysis
16
2015
260
0.480
Why?
Caregivers
4
2006
197
0.480
Why?
Time Factors
19
2020
1433
0.480
Why?
Risk-Taking
2
2011
34
0.460
Why?
Europe
14
2009
58
0.450
Why?
Frontal Lobe
4
2018
81
0.440
Why?
Sclerosis
6
2020
66
0.440
Why?
Mood Disorders
2
2003
27
0.420
Why?
Surveys and Questionnaires
12
2018
1144
0.420
Why?
Polymorphism, Single Nucleotide
5
2021
278
0.410
Why?
Urinary Retention
3
2004
13
0.410
Why?
Genome-Wide Association Study
5
2021
280
0.410
Why?
Social Class
3
2022
67
0.400
Why?
Health Status
7
2019
218
0.400
Why?
Personality
3
2021
53
0.390
Why?
Cerebrovascular Disorders
4
2021
133
0.390
Why?
Child, Preschool
14
2013
641
0.380
Why?
Cause of Death
3
2009
60
0.380
Why?
Child
17
2013
1295
0.380
Why?
Comorbidity
8
2018
481
0.380
Why?
Adolescent
19
2018
2172
0.370
Why?
Finasteride
2
2004
3
0.370
Why?
Risk Assessment
7
2015
624
0.370
Why?
Statistics as Topic
6
2017
105
0.360
Why?
Illinois
5
2020
250
0.360
Why?
Urologic Diseases
3
2003
5
0.350
Why?
Enzyme Inhibitors
2
2004
114
0.350
Why?
Mental Health
4
2019
108
0.350
Why?
Environmental Health
1
2010
8
0.350
Why?
Phobic Disorders
1
2010
66
0.340
Why?
Models, Statistical
5
2012
127
0.340
Why?
Brain Infarction
4
2018
75
0.340
Why?
Genetic Predisposition to Disease
3
2018
381
0.330
Why?
Socioeconomic Factors
4
2019
302
0.330
Why?
Psychomotor Performance
6
2019
205
0.330
Why?
Death
2
2020
47
0.330
Why?
Data Collection
1
2010
91
0.330
Why?
Neurologic Examination
4
2020
100
0.320
Why?
Infant
12
2009
564
0.320
Why?
Diffusion Tensor Imaging
2
2020
61
0.310
Why?
Linear Models
7
2018
247
0.310
Why?
Multifactorial Inheritance
3
2018
23
0.310
Why?
Severity of Illness Index
11
2015
879
0.300
Why?
Brain Diseases
3
2020
66
0.300
Why?
Lewy Body Disease
5
2018
97
0.300
Why?
Frontotemporal Lobar Degeneration
2
2019
29
0.300
Why?
Brain Neoplasms
3
1994
86
0.290
Why?
Self Report
5
2022
223
0.290
Why?
Parkinsonian Disorders
2
2014
225
0.290
Why?
Prognosis
5
2017
785
0.290
Why?
Isometric Contraction
1
2007
13
0.280
Why?
5-alpha Reductase Inhibitors
2
2004
3
0.280
Why?
Executive Function
2
2021
111
0.280
Why?
Lower Extremity
1
2007
38
0.280
Why?
Adaptation, Psychological
2
2022
175
0.270
Why?
Trust
2
2019
12
0.270
Why?
Infant, Newborn
10
2009
642
0.270
Why?
Urination Disorders
2
2003
6
0.260
Why?
Gait
2
2007
412
0.260
Why?
Postural Balance
1
2007
117
0.250
Why?
Behavior Therapy
1
2006
86
0.250
Why?
Primary Prevention
2
2019
29
0.250
Why?
Sex Characteristics
3
2022
116
0.250
Why?
Biomarkers
4
2025
562
0.250
Why?
Stress, Psychological
4
2014
235
0.250
Why?
Self Efficacy
1
2005
53
0.240
Why?
Atrophy
3
2021
91
0.240
Why?
Cost of Illness
1
2005
50
0.240
Why?
Reference Values
3
2020
186
0.240
Why?
Sex Distribution
6
2012
78
0.240
Why?
Cerebral Cortex
3
2019
155
0.240
Why?
Interpersonal Relations
3
2014
101
0.240
Why?
Age Distribution
6
2007
85
0.230
Why?
Demography
3
2018
72
0.230
Why?
Personal Satisfaction
2
2016
43
0.230
Why?
Gray Matter
2
2016
50
0.230
Why?
Neural Pathways
3
2014
63
0.230
Why?
Adrenergic alpha-Antagonists
1
2004
4
0.230
Why?
Data Interpretation, Statistical
2
2022
77
0.220
Why?
Longevity
3
2013
31
0.220
Why?
Anxiety
3
2019
156
0.220
Why?
Problem Solving
1
2004
40
0.220
Why?
Cholinesterase Inhibitors
1
2003
14
0.220
Why?
Government Agencies
1
2023
4
0.220
Why?
Mouth Neoplasms
5
1997
21
0.210
Why?
Apolipoproteins E
3
2013
251
0.210
Why?
Adenocarcinoma
5
2001
137
0.210
Why?
Anxiety Disorders
2
2016
171
0.210
Why?
Individuality
2
2021
23
0.210
Why?
Motivation
1
2003
85
0.210
Why?
Anisotropy
2
2020
44
0.210
Why?
Infarction
1
2023
29
0.200
Why?
Erectile Dysfunction
1
2003
58
0.200
Why?
Models, Theoretical
1
2003
85
0.200
Why?
Mental Recall
2
2020
62
0.200
Why?
Mental Status and Dementia Tests
2
2019
56
0.200
Why?
Prefrontal Cortex
2
2014
136
0.200
Why?
Reaction Time
2
2020
102
0.200
Why?
Survival Rate
3
2012
342
0.200
Why?
Motor Skills
2
2013
48
0.200
Why?
Laryngeal Neoplasms
2
1996
34
0.200
Why?
Predictive Value of Tests
7
2008
474
0.190
Why?
Psychometrics
3
2014
220
0.180
Why?
Healthy Volunteers
1
2021
40
0.180
Why?
Memory and Learning Tests
1
2020
7
0.180
Why?
Serial Learning
1
2020
7
0.180
Why?
Mental Disorders
2
2018
141
0.180
Why?
Healthy Aging
1
2020
14
0.170
Why?
Neurons
2
2013
339
0.170
Why?
tau Proteins
5
2025
232
0.170
Why?
Antihypertensive Agents
2
2020
55
0.170
Why?
Gait Disorders, Neurologic
1
2002
133
0.170
Why?
Musculoskeletal Diseases
2
2010
44
0.170
Why?
Space Perception
1
2019
22
0.170
Why?
Depressive Disorder, Major
2
2016
100
0.160
Why?
Self Concept
1
2020
37
0.160
Why?
Frailty
1
2020
34
0.160
Why?
Testicular Neoplasms
2
1998
20
0.160
Why?
Uterine Cervical Neoplasms
2
1998
30
0.160
Why?
Korea
3
2003
10
0.160
Why?
Neuronal Plasticity
1
2019
47
0.160
Why?
Emergencies
1
2019
32
0.150
Why?
Kidney
2
2010
153
0.150
Why?
Renal Dialysis
1
1999
84
0.150
Why?
Computer Graphics
1
1998
4
0.150
Why?
Neurodevelopmental Disorders
1
2018
18
0.150
Why?
Mental Status Schedule
3
2007
90
0.150
Why?
Lung
2
2009
168
0.150
Why?
Amyotrophic Lateral Sclerosis
1
2018
22
0.150
Why?
Kidney Failure, Chronic
1
1999
124
0.140
Why?
Smoking
7
2000
176
0.140
Why?
Alcohol Drinking
4
1996
75
0.140
Why?
Gene Expression Regulation
2
2016
271
0.140
Why?
Muscle Weakness
2
2008
34
0.140
Why?
Gallbladder Neoplasms
2
1999
6
0.140
Why?
Connecticut
8
2002
9
0.140
Why?
Registries
5
2003
189
0.140
Why?
Social Behavior
2
2011
67
0.140
Why?
Salivary Gland Neoplasms
1
1997
6
0.140
Why?
Logistic Models
6
2016
395
0.140
Why?
Pain
2
2010
413
0.140
Why?
Brain Stem
2
2016
19
0.140
Why?
Deafness
1
1997
13
0.130
Why?
Gene Expression
1
2017
199
0.130
Why?
RNA, Messenger
1
2017
310
0.130
Why?
Personality Development
1
2016
5
0.130
Why?
Cochlear Implantation
1
1997
22
0.130
Why?
Locus Coeruleus
2
2013
21
0.130
Why?
Germinoma
1
1996
1
0.130
Why?
Neurotic Disorders
2
2018
19
0.130
Why?
DNA Methylation
1
2017
161
0.130
Why?
Affect
1
2016
60
0.130
Why?
Fetus
1
2016
38
0.130
Why?
Thyroid Neoplasms
1
1996
44
0.130
Why?
Intelligence
1
2016
18
0.130
Why?
Psychological Tests
2
2015
52
0.130
Why?
Brain Chemistry
1
2016
43
0.130
Why?
Comprehension
1
2016
31
0.120
Why?
Psychiatric Status Rating Scales
5
2016
310
0.120
Why?
Brain-Derived Neurotrophic Factor
1
2016
46
0.120
Why?
Vascular Diseases
2
2013
42
0.120
Why?
Breast Neoplasms
4
2002
409
0.120
Why?
Organ Size
1
2015
95
0.120
Why?
Risk Reduction Behavior
1
2015
40
0.120
Why?
Poverty
1
2015
96
0.110
Why?
Gyrus Cinguli
1
2014
14
0.110
Why?
Harm Reduction
1
2014
6
0.110
Why?
Muscle, Skeletal
2
2008
383
0.110
Why?
Music
1
2014
23
0.110
Why?
Anticarcinogenic Agents
2
2000
18
0.110
Why?
Multilingualism
1
2014
21
0.110
Why?
Language
2
2014
63
0.110
Why?
Prenatal Exposure Delayed Effects
1
1994
6
0.110
Why?
Mesencephalon
1
2013
24
0.110
Why?
Case-Control Studies
6
2002
587
0.110
Why?
Medicare Part D
1
2013
7
0.110
Why?
Image Processing, Computer-Assisted
4
2016
164
0.110
Why?
France
3
2003
12
0.110
Why?
Cerebellum
1
2013
43
0.110
Why?
Lung Neoplasms
4
2003
552
0.110
Why?
Clinical Trials as Topic
1
2014
216
0.110
Why?
Scotland
5
1998
6
0.110
Why?
Retirement
2
2011
12
0.110
Why?
Causality
3
2012
56
0.100
Why?
Psychomotor Disorders
1
2013
11
0.100
Why?
Neuroticism
3
2021
32
0.100
Why?
Retinoids
1
1992
5
0.100
Why?
Leukoplakia, Oral
1
1992
3
0.100
Why?
Epidemiologic Research Design
1
2012
15
0.100
Why?
Diagnosis, Differential
2
2004
348
0.100
Why?
Antibodies, Antiphospholipid
1
2012
23
0.100
Why?
Colonic Neoplasms
2
2000
58
0.100
Why?
Child Abuse
1
2012
32
0.100
Why?
Terminally Ill
1
2012
5
0.100
Why?
Health Surveys
2
2007
86
0.100
Why?
Models, Psychological
1
2012
69
0.100
Why?
Emotions
1
2012
72
0.100
Why?
Movement Disorders
1
2012
66
0.100
Why?
Urban Population
2
2010
153
0.100
Why?
Respiratory Muscles
2
2008
17
0.090
Why?
England
2
2003
14
0.090
Why?
Alleles
4
2015
216
0.090
Why?
Acute Disease
3
2004
176
0.090
Why?
Social Environment
1
2011
76
0.090
Why?
Odorants
2
2009
22
0.090
Why?
Social Participation
1
2011
12
0.090
Why?
Motor Skills Disorders
1
2010
15
0.090
Why?
Leg
2
2008
50
0.090
Why?
Knowledge
1
2010
17
0.090
Why?
Potassium
2
2010
62
0.090
Why?
Beer
1
1990
2
0.090
Why?
Alcoholic Beverages
1
1990
3
0.090
Why?
Patient Satisfaction
2
2003
317
0.090
Why?
Physical Fitness
2
2008
51
0.090
Why?
Housing for the Elderly
1
2010
8
0.080
Why?
Neuroimaging
2
2022
126
0.080
Why?
Muscle Strength Dynamometer
1
2009
17
0.080
Why?
Attitude to Health
2
2003
99
0.080
Why?
United Kingdom
3
2016
47
0.080
Why?
Prevalence
3
2012
443
0.080
Why?
Social Adjustment
1
2009
23
0.080
Why?
Confidence Intervals
3
2012
94
0.080
Why?
Pancreatic Neoplasms
1
1990
93
0.080
Why?
Renal Insufficiency, Chronic
1
2009
44
0.080
Why?
Olfaction Disorders
1
2009
49
0.080
Why?
Community Health Services
1
2009
34
0.080
Why?
Sensitivity and Specificity
2
2021
482
0.070
Why?
Odds Ratio
4
2002
270
0.070
Why?
Depressive Disorder
3
2007
177
0.070
Why?
Forecasting
2
2009
91
0.070
Why?
Epidemiologic Studies
2
2005
24
0.070
Why?
Peripheral Nervous System Diseases
1
2007
28
0.070
Why?
Hand Strength
1
2007
58
0.070
Why?
Reproducibility of Results
2
2014
676
0.070
Why?
Epidemiology
1
2007
5
0.070
Why?
Observation
1
2007
7
0.070
Why?
Carcinoma, Squamous Cell
3
2001
172
0.070
Why?
Massachusetts
1
2006
19
0.070
Why?
Diet
4
2000
220
0.070
Why?
Netherlands
2
2003
26
0.070
Why?
Exercise Therapy
1
2007
88
0.060
Why?
Cerebral Arteries
1
2005
25
0.060
Why?
Genetic Loci
2
2018
51
0.060
Why?
Interview, Psychological
1
2005
41
0.060
Why?
Rectal Neoplasms
1
1985
14
0.060
Why?
Home Nursing
1
2005
33
0.060
Why?
Sertraline
2
2002
24
0.060
Why?
Retrospective Studies
4
2019
3538
0.060
Why?
Neurofilament Proteins
1
2025
17
0.060
Why?
Models, Biological
1
1987
322
0.060
Why?
Glial Fibrillary Acidic Protein
1
2025
43
0.060
Why?
Social Support
2
2020
196
0.060
Why?
Treatment Outcome
4
2006
3485
0.060
Why?
New South Wales
2
1994
3
0.060
Why?
Heterozygote
2
2015
100
0.050
Why?
Libido
1
2003
6
0.050
Why?
Ejaculation
1
2003
9
0.050
Why?
Australia
3
1999
40
0.050
Why?
Young Adult
3
2018
1994
0.050
Why?
Cardiovascular Diseases
1
2007
321
0.050
Why?
Vital Statistics
1
2003
1
0.050
Why?
Azasteroids
1
2003
2
0.050
Why?
Multicenter Studies as Topic
1
2003
43
0.050
Why?
Health Care Surveys
1
2003
64
0.050
Why?
Genotype
2
2015
346
0.050
Why?
Carcinoma, Small Cell
2
2001
54
0.050
Why?
Survival Analysis
1
2003
257
0.050
Why?
Program Evaluation
1
2003
120
0.050
Why?
Observer Variation
1
2003
96
0.050
Why?
Hair Dyes
1
2002
1
0.050
Why?
Italy
3
1990
12
0.050
Why?
Mendelian Randomization Analysis
1
2021
8
0.050
Why?
Computer Simulation
1
2003
195
0.050
Why?
Epidemiologic Methods
2
2015
17
0.050
Why?
Mitochondrial Proteins
1
2021
41
0.050
Why?
Health Behavior
2
2014
159
0.050
Why?
Brazil
1
2021
41
0.050
Why?
Antidepressive Agents
1
2002
97
0.050
Why?
beta-Lactamases
1
2021
98
0.040
Why?
Spouses
1
2000
32
0.040
Why?
Membrane Proteins
1
2021
165
0.040
Why?
Switzerland
2
1990
8
0.040
Why?
Nails
1
2000
1
0.040
Why?
Selenium
1
2000
10
0.040
Why?
Machine Learning
1
2020
79
0.040
Why?
New Zealand
1
1999
11
0.040
Why?
Frontotemporal Dementia
1
2019
13
0.040
Why?
Sleep Wake Disorders
1
2000
123
0.040
Why?
Body Mass Index
2
2012
458
0.040
Why?
Wales
1
1998
5
0.040
Why?
Spain
1
1998
8
0.040
Why?
Proteomics
1
2019
89
0.040
Why?
Poisson Distribution
1
1998
22
0.040
Why?
Prostatic Neoplasms
1
2000
112
0.040
Why?
Algorithms
1
2021
350
0.040
Why?
Immunohistochemistry
1
2019
366
0.040
Why?
Japan
4
2001
5
0.040
Why?
Religious Personnel
1
2018
11
0.040
Why?
Protein-Arginine Deiminases
1
2017
11
0.040
Why?
alpha-Macroglobulins
1
2017
13
0.040
Why?
Exercise
2
2012
450
0.040
Why?
Sequence Analysis, RNA
1
2017
43
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2017
44
0.040
Why?
Gingival Neoplasms
1
1997
1
0.030
Why?
Surgical Procedures, Operative
1
1997
29
0.030
Why?
Sampling Studies
3
2002
29
0.030
Why?
Papillomaviridae
1
1996
19
0.030
Why?
Adenocarcinoma, Follicular
1
1996
8
0.030
Why?
Time
1
1996
15
0.030
Why?
Tumor Virus Infections
1
1996
17
0.030
Why?
Carcinoma, Papillary
1
1996
21
0.030
Why?
Meta-Analysis as Topic
1
2016
39
0.030
Why?
Papillomavirus Infections
1
1996
20
0.030
Why?
Neoplasms, Radiation-Induced
1
1996
12
0.030
Why?
Molecular Sequence Annotation
1
2016
4
0.030
Why?
Radiotherapy
1
1996
31
0.030
Why?
Occupational Diseases
1
1996
22
0.030
Why?
Computational Biology
1
2016
21
0.030
Why?
Gene-Environment Interaction
1
2016
18
0.030
Why?
Seminoma
1
1996
2
0.030
Why?
Vulnerable Populations
1
2016
23
0.030
Why?
ROC Curve
1
2016
141
0.030
Why?
Vitamin A
2
1993
8
0.030
Why?
Schizophrenia
1
2016
62
0.030
Why?
Bayes Theorem
1
2016
42
0.030
Why?
Speech Perception
1
1997
49
0.030
Why?
SEER Program
1
1996
42
0.030
Why?
Family Practice
1
1995
15
0.030
Why?
Randomized Controlled Trials as Topic
1
1997
292
0.030
Why?
Urology
1
1995
17
0.030
Why?
Disease Susceptibility
1
2016
71
0.030
Why?
Bipolar Disorder
1
2016
130
0.030
Why?
Markov Chains
1
2015
33
0.030
Why?
Diffusion Magnetic Resonance Imaging
1
2016
89
0.030
Why?
Genetic Association Studies
1
2015
83
0.030
Why?
Phenotype
1
2016
312
0.030
Why?
Life Change Events
1
2014
37
0.030
Why?
Canada
2
1994
47
0.030
Why?
Empathy
1
2014
39
0.030
Why?
Raphe Nuclei
1
2013
7
0.030
Why?
Ventral Tegmental Area
1
2013
9
0.030
Why?
Carcinoma
1
1994
67
0.030
Why?
Image Interpretation, Computer-Assisted
1
2014
64
0.030
Why?
Lip Neoplasms
1
1993
2
0.030
Why?
World Health Organization
3
2003
9
0.030
Why?
Cell Count
1
2013
81
0.030
Why?
Fathers
1
1994
22
0.030
Why?
Magnetic Resonance Spectroscopy
1
2013
39
0.030
Why?
Religion
1
2013
41
0.030
Why?
Endophenotypes
1
2013
11
0.030
Why?
Stomach Neoplasms
1
1993
34
0.030
Why?
Isotretinoin
1
1992
8
0.030
Why?
Substantia Nigra
1
2013
120
0.030
Why?
Pregnancy
1
1994
336
0.030
Why?
Carotenoids
1
1992
18
0.030
Why?
Poland
1
1992
2
0.030
Why?
Coffee
1
1992
3
0.030
Why?
Neocortex
1
2012
31
0.020
Why?
Lymphoma, Non-Hodgkin
1
1992
36
0.020
Why?
Respiratory Tract Neoplasms
1
1992
1
0.020
Why?
Actigraphy
1
2012
100
0.020
Why?
Energy Intake
1
1992
83
0.020
Why?
Esophageal Neoplasms
1
1992
50
0.020
Why?
Games, Experimental
1
2011
7
0.020
Why?
Energy Metabolism
1
2012
54
0.020
Why?
Probability
1
2011
88
0.020
Why?
Nerve Net
1
2011
40
0.020
Why?
Oxygen
1
2011
68
0.020
Why?
Parents
1
2012
113
0.020
Why?
Visual Perception
1
2011
30
0.020
Why?
Soft Tissue Neoplasms
1
1992
54
0.020
Why?
Skin Neoplasms
1
1992
80
0.020
Why?
Bulgaria
1
1990
1
0.020
Why?
Czechoslovakia
1
1990
1
0.020
Why?
Germany, West
1
1990
1
0.020
Why?
Yugoslavia
1
1990
2
0.020
Why?
Research Design
1
2012
185
0.020
Why?
Denmark
1
1990
10
0.020
Why?
Wine
1
1990
7
0.020
Why?
Statistics, Nonparametric
1
2010
125
0.020
Why?
Animals
1
1998
3642
0.020
Why?
Bone Neoplasms
1
1992
130
0.020
Why?
Respiratory Function Tests
1
2009
32
0.020
Why?
Hodgkin Disease
1
1989
19
0.020
Why?
Microcirculation
1
2009
29
0.020
Why?
Glomerular Filtration Rate
1
2009
39
0.020
Why?
Extremities
1
2008
27
0.020
Why?
Tissue Donors
1
2009
79
0.020
Why?
Catholicism
1
2007
20
0.020
Why?
Models, Neurological
1
2007
25
0.020
Why?
Exercise Tolerance
1
2007
31
0.020
Why?
Clergy
1
2007
92
0.020
Why?
Porphyrias
1
1985
1
0.020
Why?
Autonomic Nervous System Diseases
1
1985
24
0.020
Why?
Dietary Proteins
1
1985
26
0.020
Why?
Dietary Fiber
1
1985
27
0.020
Why?
Dietary Fats
1
1985
39
0.020
Why?
Cohort Effect
2
1994
2
0.010
Why?
Dutasteride
1
2003
2
0.010
Why?
Single-Blind Method
1
2003
102
0.010
Why?
Death Certificates
1
2003
1
0.010
Why?
Citalopram
1
2002
8
0.010
Why?
Antidepressive Agents, Second-Generation
1
2002
28
0.010
Why?
Color
1
2002
7
0.010
Why?
Outpatients
1
2002
61
0.010
Why?
Slovakia
1
2001
1
0.010
Why?
Bendroflumethiazide
1
1980
1
0.010
Why?
Metolazone
1
1980
1
0.010
Why?
Diuretics
1
1980
2
0.010
Why?
Hawaii
1
2000
2
0.010
Why?
Neutron Activation Analysis
1
2000
1
0.010
Why?
Toes
1
2000
6
0.010
Why?
Population Surveillance
1
2000
115
0.010
Why?
Cholelithiasis
1
1999
6
0.010
Why?
Cholecystectomy, Laparoscopic
1
1999
20
0.010
Why?
Cross-Cultural Comparison
1
1999
39
0.010
Why?
Biomarkers, Tumor
1
2000
205
0.010
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
1994
2
0.010
Why?
North America
1
1994
41
0.010
Why?
Public Health
1
1994
69
0.010
Why?
Cardia
1
1993
3
0.010
Why?
Helicobacter Infections
1
1993
2
0.010
Why?
Hernia, Hiatal
1
1993
13
0.010
Why?
Tongue Neoplasms
1
1992
19
0.010
Why?
Pleural Neoplasms
1
1992
11
0.010
Why?
Valsalva Maneuver
1
1985
3
0.000
Why?
Parasympathetic Nervous System
1
1985
2
0.000
Why?
Sympathetic Nervous System
1
1985
13
0.000
Why?
Respiration
1
1985
35
0.000
Why?
Posture
1
1985
63
0.000
Why?
Muscle Contraction
1
1985
67
0.000
Why?
Heart Rate
1
1985
114
0.000
Why?
Boyle's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (548)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_